Featuring j2 Global (NASDAQ: JCOM) and Cancer Genetics (NASDAQ: CGIX)

If you can't read this email Click Here

 
 

 

WEEKLY

DIGITAL MAGAZINE

Open Magazine

 

THIS WEEK

Featuring j2 Global and Cancer Genetics

In this week's edition of the "The RedChip Money Report" we're featuring j2 Global (NASDAQ: JCOM) and Cancer Genetics (NASDAQ: CGIX).

j2 Global, a global provider of internet services, raised 2015 revenue and non-GAAP earnings guidance on the heels of nine completed acquisitions.

Cancer Genetics, an emerging leader in DNA-based cancer diagnostics, received bankruptcy court approval to move forward on its acquisition of the assets of Response Genetics, paving the way for further product expansion and improved geographic coverage in the U.S.

Learn more about JCOM, CGIX, and other RedChip Nation stocks in this week's edition of "The RedChip Money Report".

 

For Further Information, Contact:
RedChip Companies, Inc.
1017 Maitland Center Commons Blvd. Maitland, FL 32751
1 (800) 733-2447
Fax: (407) 644-0758
[email protected]
Visit: www.RedChip.com